PRICE T ROWE ASSOCIATES INC /MD/
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 80255
BALTIMORE, MD
Position in ACAD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,127,575
-$2,303,588 QoQ
Shares Held
634,662
+3.2% QoQ
Ownership
0.371%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.70850626002502.ToString("F0")%
Shared 0.ToString("F0")%
None 0.29149373997497885.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. ACAD ranks #93 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,127,575 | 634,662 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,431,163 | 615,169 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $23,492,842 | 1,100,883 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,033,158 | 928,751 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,786,184 | 649,379 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,395,533 | 621,010 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,150,245 | 659,964 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,951,397 | 920,086 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $73,951,679 | 3,999,550 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $162,139,116 | 5,178,509 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $108,996,554 | 5,230,161 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $144,033,239 | 6,013,914 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $85,648,050 | 4,550,906 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $68,125,723 | 4,279,254 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $80,022,453 | 4,891,348 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $66,134,444 | 4,693,715 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $120,589,829 | 4,978,936 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $221,409,331 | 9,486,261 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $156,674,555 | 9,432,544 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $248,749,488 | 10,198,831 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $215,533,483 | 8,354,011 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $421,148,524 | 7,877,825 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $434,656,942 | 10,537,138 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $549,736,367 | 11,341,786 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $499,728,986 | 11,827,905 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||